Skip to main content
. 2022 Sep 27;9(1):e000985. doi: 10.1136/bmjgast-2022-000985

Table 1.

Study design and treatment schedule

Group No of mice Test substance Dose (mg/kg) Volume (mL/kg) Regimen Sacrifice
1 8 Vehicle 5 PO, QD,
6–9 weeks
9 weeks
2 8 AFO-202 Beta
Glucan
1 5 PO, QD,
6–9 weeks
9 weeks
3 8 N-163 Beta Glucan 1 5 PO, QD,
6–9 weeks
9 weeks
4 8 AFO-202 Beta
Glucan N-163 Beta
Glucan
1
1
5 PO, QD,
6–9 weeks
9 weeks
5 8 Telmisartan 10 5 PO, QD,
6–9 weeks
9 weeks

PO, per os; QD, every day.